查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024640

流感診斷市場報告：按產品類型、檢測類型、流感類型、最終用戶和地區分類（2026-2034 年）

Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年全球流感診斷市場規模達10.665億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到16.68億美元，2026年至2034年的複合年成長率為4.94%。推動市場成長的因素包括：疫苗接種工作的擴大、即時檢測的便利性、流感病毒研究的活性化以及公共衛生計畫提高公眾意識等。

流感，俗稱“普通感冒”，是一種主要侵襲呼吸系統的病毒感染疾病，包括鼻、咽喉和肺部。流感檢體涉及一系列免疫檢測，旨在識別呼吸道檢體中甲型和乙型流感病毒的核蛋白抗原。可用的診斷方法包括快速抗原檢測、逆轉錄聚合酵素鏈鎖反應(RT-PCR)、螢光檢測、血清學檢測和快速分子檢測。相關人員依靠這些檢測來快速檢測和分類流感病毒株，從而支持有效的治療決策和公共衛生管理。診斷技術的不斷進步和對流感病毒的持續研究正在提高這些檢測的效率和可靠性。在醫護人員努力應對季節性流感爆發和潛在的大流行之際，準確的診斷仍然是快速干預和製定科學醫療策略的基礎。

全球市場的主要驅動力是流感疫情的不斷加劇。加之全球對潛在流行病的日益擔憂，促使人們加大對診斷能力的投資，從而顯著推動了市場成長。此外，技術的快速進步提高了診斷測試的準確性和速度，對市場產生了積極影響。同時，公眾宣傳活動的提升也鼓勵更多人及時接受檢測，進一步刺激了市場。醫療保健成本的上漲也推動了先進診斷方法的應用，進一步促進了市場發展。老年人更容易患重病，因此對診斷的需求不斷成長。此外，都市區的成長導致感染率上升，因此需要更可靠的診斷。頻繁的旅行加速了流感的傳播，使得高效的診斷至關重要。這些因素為市場帶來了許多機會。

流感診斷市場的趨勢與促進因素：

方便就醫

便捷的醫療服務正在推動市場成長。醫療設施的改善意味著人們能夠及時接受流感感染的診斷檢測。當醫療服務唾手可得時，人們更有可能在症狀早期接受檢測，從而實現早期發現和適當干預。這種及時的應對措施不僅可以防止病毒傳播，還有助於改善患者的治療效果。此外，便利的醫療服務也促進了各種診斷方法的普及，包括無需大規模檢查室即可快速獲得檢測結果的即時檢測（POC​​T）。這種便利的醫療環境為診斷設備製造商、醫療服務提供者和患者創造了有利的生態系統，最終促進了市場成長。

多種慢性疾病盛行率增加

多種慢性疾病的日益普遍正在推動市場成長。糖尿病、心血管疾病和呼吸系統疾病等慢性疾病會削弱免疫系統，使個體更容易感染嚴重流感。隨著慢性疾病患者人數的增加，對準確、早期流感診斷的需求也日益成長。慢性疾病患者發生流感併發症的風險更高，因此需要快速檢測和個人化的醫療介入。醫療專業人員優先為這些易感人群進行檢測，以減輕潛在併發症並提供及時治療。此外，慢性疾病與流感之間的相互關聯凸顯了採用綜合診斷方法的必要性。對患有潛在疾病的患者進行準確的流感診斷，有助於醫療專業人員制定個人化的治療方案，有效控制併發症，並改善患者預後。隨著慢性疾病在全球範圍內持續增加，對流感診斷的需求對於保護患有基礎疾病人群的健康至關重要。這種持續的需求是市場成長的主要驅動力。

人工智慧（AI）的快速普及

人工智慧 (AI) 的快速普及正對市場產生正面影響。 AI 技術透過提高流感檢測的準確性、速度和效率，正在革新診斷能力。 AI 演算法分析來自各種來源的大量數據，包括患者病歷、症狀和檢測結果，從而提供更準確、更個人化的診斷資訊。這加快了流感患者的識別速度，使醫療干預和公共衛生應對措施及時到位。機器學習和 AI 演算法也在改進流感爆發預測模型。透過分析歷史數據、模式和環境因素，這些技術可以預測潛在的流感爆發，幫助醫療機構有效地做好準備和分配資源。此外，AI 影像分析有助於評估胸部 X 光片等醫學影像，從而識別流感相關併發症並準確監測疾病進展。 AI 的快速普及正在改變我們的診斷方式，為醫療專業人員提供先進的工具，以做出更明智的決策並提供更精準的患者照護。這一趨勢正在為市場做出重大貢獻。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球流感診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 檢測套組和試劑
  • 裝置
  • 其他

第7章 市場區隔：依測試類型分類

  • 分子診斷測試
    • 主要部分
      • 聚合酵素鏈鎖反應
      • 恒溫核酸增幅檢測
      • 其他分子檢測
  • 常規診斷測試
    • 主要部分
      • 快速流感診斷測試
      • 病毒培養試驗
      • 直接螢光測定
      • 血清學檢測

第8章 市場區隔：依流感類型分類

  • 甲型流感
  • 乙型流感
  • 丙型流感

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷檢查室
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Cepheid（Danaher Corporation）
    • Coris BioConcept
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd
    • Hologic, Inc.
    • Meridian Bioscience Inc.
    • Qiagen NV
    • QuidelOrtho Corporation
    • SEKISUI Diagnostics
    • Siemens Healthcare Diagnostics GmbH
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6053

The global influenza diagnostics market size reached USD 1,066.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,668.0 Million by 2034, exhibiting a growth rate (CAGR) of 4.94% during 2026-2034. The increasing vaccination efforts, the convenience of point-of-care tests, the rising research into flu viruses, and the growing awareness through public health programs are some of the factors propelling the market.

Influenza, commonly known as the flu, is a viral infection primarily targeting the respiratory system, encompassing the nose, throat, and lungs. Influenza diagnostics encompasses an array of immunoassay tests designed to identify the presence of influenza A and B viral nucleoprotein antigens within respiratory samples. Among the diagnostic options available are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. The medical fraternity relies on these tests to detect and categorize influenza strains promptly, aiding in effective treatment decisions and public health management. The continual evolution of diagnostic techniques and the ongoing research into influenza viruses enhance the efficiency and reliability of these tests. As healthcare providers strive to combat seasonal flu outbreaks and potential pandemics, accurate diagnostics remain a cornerstone, enabling swift intervention and informed medical strategies.

The global market is majorly driven by the increasing occurrence of flu outbreaks. In line with this, the rising global concerns about potential pandemics drive investments in diagnostic capabilities, significantly contributing to the market. Furthermore, rapid technological innovations improve the accuracy and speed of diagnostic tests, positively influencing the market. Apart from this, the growing public awareness campaigns encourage more individuals to seek timely testing, catalyzing the market. Moreover, the escalating healthcare spending supports the adoption of advanced diagnostic methods, propelling the market. Besides, elderly individuals are more susceptible to severe flu, boosting demand for diagnostics. Additionally, the increasing urban populations contribute to higher infection rates, requiring robust diagnostics. Frequent travel accelerates the spread of the flu, necessitating efficient diagnostics. This, in turn, offers numerous opportunities for the market.

INFLUENZA DIAGNOSTICS MARKET TRENDS/DRIVERS:

Easy access to healthcare

The easy access to healthcare is stimulating market growth. Improved accessibility to medical facilities encourages individuals to seek timely diagnostic testing for flu infections. When healthcare services are easily reachable, people are more inclined to undergo testing at the onset of symptoms, leading to early detection and appropriate intervention. This timely approach not only aids in preventing the spread of the virus but also facilitates better patient outcomes. Furthermore, convenient access to healthcare facilities supports the adoption of various diagnostic methods, including point-of-care testing, which provides rapid results without requiring extensive laboratory infrastructure. This accessible healthcare environment creates a favorable ecosystem for diagnostic manufacturers, healthcare providers, and patients, ultimately contributing to market growth.

Increasing prevalence of several chronic diseases

The increasing prevalence of several chronic diseases is catalyzing the market. Chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, weaken the immune system and make individuals more susceptible to severe flu infections. As the number of individuals affected by these chronic conditions rises, the demand for accurate and early influenza diagnostics intensifies. Patients with chronic diseases are at a higher risk of complications from the flu, necessitating prompt detection and tailored medical interventions. Healthcare providers prioritize testing these vulnerable populations to mitigate potential complications and provide timely treatment. Moreover, the interconnectedness of chronic diseases and flu underscores the need for comprehensive diagnostic approaches. Accurate flu diagnosis in individuals with pre-existing conditions enables healthcare professionals to tailor treatment plans, manage complications effectively, and improve patient outcomes. As chronic diseases continue to increase globally, the demand for influenza diagnostics becomes integral in safeguarding the health of individuals with underlying conditions. This ongoing demand significantly contributes to the market.

Rapid integration of artificial intelligence

The rapid integration of artificial intelligence (AI) is favorably impacting the market. AI technologies are revolutionizing diagnostic capabilities by enhancing flu detection accuracy, speed, and efficiency. AI-powered algorithms can analyze vast amounts of data from various sources, including patient histories, symptoms, and test results, to provide more precise and tailored diagnostic insights. This accelerates the identification of flu cases, enabling timely medical interventions and public health responses. Machine learning and AI algorithms also improve predictive modeling for flu outbreaks. By analyzing historical data, patterns, and environmental factors, these technologies aid in forecasting potential flu epidemics, assisting healthcare organizations in preparing and allocating resources effectively. Additionally, AI-driven image analysis assists in evaluating medical images, such as chest X-rays, to identify flu-related complications and monitor disease progression accurately. The rapid pace of AI integration is transforming the diagnostic landscape, offering healthcare professionals advanced tools for more informed decision-making and precise patient care. This trend contributes significantly to the market.

INFLUENZA DIAGNOSTICS INDUSTRY SEGMENTATION:

Breakup by Product:

  • Test Kit and Reagents
  • Instruments
  • Others

Test Kit and Reagents dominates the market

Test kit and reagents form the foundation of diagnostic procedures, providing the necessary chemical components for identifying viral antigens and antibodies in patient samples. These kits enable healthcare professionals to swiftly and accurately diagnose influenza infections, facilitating timely medical interventions and public health responses. The continuous innovation in test kit technology, including improved sensitivity and specificity, contributes to heightened accuracy in flu detection.

On the other hand, instruments encompass the equipment for processing and analyzing samples, automating diagnostic workflows, and delivering reliable results. These instruments, ranging from PCR machines to automated immunoassay platforms, streamline the testing process, reduce human errors, and enhance the overall efficiency of diagnostics.

Breakup by Test Type:

  • Molecular Diagnostic Tests
    • Polymerase Chain Reaction
    • Isothermal Nucleic Acid Amplification Tests
    • Other Molecular Tests
  • Traditional Diagnostic Tests
    • Rapid Influenza Diagnostic Tests
    • Viral Culture Tests
    • Direct Fluorescent Antibody Test
    • Serological Tests

Traditional Diagnostic Test dominates the market

Traditional diagnostic tests encompass methods like rapid antigen testing and immunofluorescence assays. While they may not offer the same level of sensitivity as molecular tests, they provide rapid results, making them invaluable in scenarios where swift diagnosis is critical for patient management and public health responses.

Molecular diagnostic tests on the other hand, utilize advanced molecular techniques such as polymerase chain reaction (PCR) and nucleic acid amplification to detect the influenza virus's genetic material directly. These tests offer high sensitivity and specificity, enabling early and accurate identification of viral infections. The increasing adoption of molecular diagnostic tests is driven by their ability to detect multiple flu strains and their potential to differentiate between seasonal and novel influenza viruses.

Breakup by Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

Type A Flu dominates the market

"Type A Flu" includes various influenza viruses, some responsible for seasonal flu outbreaks and potential pandemics. Accurate differentiation of specific Type A strains is essential for targeted treatment and surveillance efforts.

Furthermore, "Type B Flu" encompasses a distinct group of viruses contributing to seasonal flu epidemics. Detecting and categorizing Type B strains aid in tailoring medical interventions and vaccine development to mitigate flu-related complications.

Moreover, "Type C Flu," although typically milder, still requires accurate diagnosis for effective patient management. While it is less likely to cause large outbreaks, its inclusion highlights the comprehensive approach to influenza diagnostics.

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Hospitals dominates the market

Hospitals encompass a significant portion of the market demand, offering immediate access to diagnostic services for patients with flu-like symptoms. Timely diagnosis within hospitals enables rapid treatment decisions and infection control measures, which are crucial for managing patient health and preventing virus spread within healthcare facilities.

Furthermore, diagnostic Laboratories are specialized hubs for accurate and thorough flu testing. These laboratories often employ advanced equipment and experienced personnel to conduct comprehensive diagnostic procedures. By focusing on high-quality diagnostics, they support healthcare providers in delivering accurate results, essential for effective patient management and public health interventions.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's emphasis on research and innovation fosters the development of cutting-edge diagnostic technologies and methodologies. This region leads in adopting advanced testing solutions that enhance the accuracy and efficiency of flu detection. Its high prevalence of chronic diseases and respiratory conditions underscores the need for accurate influenza diagnostics. With a focus on timely detection, healthcare providers in North America rely on a wide range of diagnostic tests to ensure prompt treatment and prevent escalating flu-related complications.

Government initiatives, awareness campaigns, and strong healthcare policies drive the demand for influenza diagnostics. The region's robust public health infrastructure emphasizes the importance of accurate diagnostics in managing seasonal outbreaks and potential pandemics. The prevalence of international travel and globalization also heightens the demand for accurate flu testing in North America, as early detection becomes crucial in preventing the importation and spread of viral strains. The region's commitment to accurate and timely diagnostics positions it as a key driver in shaping the industry's expansion.

COMPETITIVE LANDSCAPE:

Top companies are bolstering the market through their innovative approaches and expertise. These companies leverage their resources and research capabilities to drive market expansion. They invest significantly in research and development, leading to the creation of advanced diagnostic technologies. These innovations, including AI-powered platforms and rapid testing solutions, enhance the accuracy and efficiency of flu detection. Top companies collaborate with healthcare providers and institutions to ensure widespread product access. These partnerships facilitate the integration of cutting-edge diagnostic solutions into existing healthcare systems, expanding market reach. Moreover, these companies often conduct awareness campaigns to educate healthcare professionals and the public about the importance of timely flu testing. These efforts drive increased demand for accurate diagnostics. Furthermore, their global presence and distribution networks enable them to provide essential diagnostic tools to regions with varying levels of healthcare infrastructure, contributing to overall market growth.

The report has provided a comprehensive analysis of the competitive landscape in the influenza diagnostics market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Cepheid (Danaher Corporation)
  • Coris BioConcept
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Qiagen N.V
  • QuidelOrtho Corporation
  • SEKISUI Diagnostics
  • Siemens Healthcare Diagnostics GmbH
  • Thermo Fisher Scientific Inc.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Influenza Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Polymerase Chain Reaction
      • 7.1.2.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.2.3 Other Molecular Tests
    • 7.1.3 Market Forecast
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Rapid Influenza Diagnostic Tests
      • 7.2.2.2 Viral Culture Tests
      • 7.2.2.3 Direct Fluorescent Antibody Test
      • 7.2.2.4 Serological Tests
    • 7.2.3 Market Forecast

8 Market Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type B Flu
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Type C Flu
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cepheid (Danaher Corporation)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Coris BioConcept
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 QuidelOrtho Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 SEKISUI Diagnostics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Siemens Healthcare Diagnostics GmbH
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2025
  • Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2025
  • Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
  • Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
  • Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million USD), 2026-2034
  • Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Influenza Diagnostics Market: Competitive Structure
  • Table 8: Global: Influenza Diagnostics Market: Key Players